Carcinoma of the Lung

• CLINICAL_TRIALS trial_result · 2018-12-21
  Clinical Trial Update: Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC [Phase 2]

  Phase 2 trial update on the efficacy and safety of anlotinib as maintenance therapy after first-line chemotherapy in small cell lung cancer.

• EMA withdrawal · 2015-03-12
  EMA Lapsed: Docetaxel Mylan (docetaxel) — Mylan S.A.S.

  EMA status shows Docetaxel Mylan has lapsed; related indications include head and neck neoplasms, non-small cell lung carcinoma, adenocarcin…